Akut coronariaszindróma miatt 2015-ben kezelt betegeink lipidcsökkentő terápiája

Márk László, Nagy Mária, Dani Győző, Baranyai Csaba, Borbély Marianna, Katona András, Z. Jambrik

Research output: Article

1 Citation (Scopus)

Abstract

Introduction: The actual guidelines of cardiovascular prevention lay special emphasis on the lipid-lowering therapy of patients suffering from acute coronary syndrome (ACS). Aim: To evaluate the occurrence of high-intensity statin therapy, recommended by guidelines, at discharge in a Hungarian county hospital with hemodynamic laboratory in patients who underwent percutaneous intervention, furthermore the LDL-cholesterol (LDL-C) levels and goal attainment rate in the first year. Method: Retrospective data collection from the hospital database regarding the therapy at discharge and the lipid levels in the year following the intervention due to ACS in 2015. Results: Due to ACS event, 454 patients had coronary intervention in 2015, at discharge more than 90% of them received high-intensity statin (more than 80% rosuvastatin, 40 mg) or corresponding combination therapy. In 154 cases we found half-year lipid results; the median of LDL-C was 1.9 mmol/L, the 1.8 mmol/L target value attainment rate was 48.7%. Results after one year were found in 292 cases (73% without the deceased and foreign patients); the LDL-C median proved to be 2.0 mmol/L, the target level attainment rate was 37.3%. There was no significant difference between the results of patients from the three different ACS forms and between those of men and women. Conclusions: The lipid lowering therapy of the revascularized patients who come back for medical visits is acceptable, but greater emphasis has to be laid on increasing the rate of controlled patients compared to the present two-thirds.

Original languageHungarian
Pages (from-to)478-484
Number of pages7
JournalOrvosi Hetilap
Volume159
Issue number12
DOIs
Publication statusPublished - márc. 1 2018

Fingerprint

County Hospitals
Acute Coronary Syndrome
Lipids
LDL Cholesterol
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Therapeutics
Guidelines
Hemodynamics
Databases

Keywords

  • Acute coronary syndrome
  • Cardiovascular prevention
  • Guidelines
  • Risk factors
  • Statins

ASJC Scopus subject areas

  • Medicine(all)

Cite this

László, M., Mária, N., Győző, D., Csaba, B., Marianna, B., András, K., & Jambrik, Z. (2018). Akut coronariaszindróma miatt 2015-ben kezelt betegeink lipidcsökkentő terápiája. Orvosi Hetilap, 159(12), 478-484. https://doi.org/10.1556/650.2018.31022

Akut coronariaszindróma miatt 2015-ben kezelt betegeink lipidcsökkentő terápiája. / László, Márk; Mária, Nagy; Győző, Dani; Csaba, Baranyai; Marianna, Borbély; András, Katona; Jambrik, Z.

In: Orvosi Hetilap, Vol. 159, No. 12, 01.03.2018, p. 478-484.

Research output: Article

László, M, Mária, N, Győző, D, Csaba, B, Marianna, B, András, K & Jambrik, Z 2018, 'Akut coronariaszindróma miatt 2015-ben kezelt betegeink lipidcsökkentő terápiája', Orvosi Hetilap, vol. 159, no. 12, pp. 478-484. https://doi.org/10.1556/650.2018.31022
László M, Mária N, Győző D, Csaba B, Marianna B, András K et al. Akut coronariaszindróma miatt 2015-ben kezelt betegeink lipidcsökkentő terápiája. Orvosi Hetilap. 2018 márc. 1;159(12):478-484. https://doi.org/10.1556/650.2018.31022
László, Márk ; Mária, Nagy ; Győző, Dani ; Csaba, Baranyai ; Marianna, Borbély ; András, Katona ; Jambrik, Z. / Akut coronariaszindróma miatt 2015-ben kezelt betegeink lipidcsökkentő terápiája. In: Orvosi Hetilap. 2018 ; Vol. 159, No. 12. pp. 478-484.
@article{d167afbd48a84787be316a8a390c9d9f,
title = "Akut coronariaszindr{\'o}ma miatt 2015-ben kezelt betegeink lipidcs{\"o}kkentő ter{\'a}pi{\'a}ja",
abstract = "Introduction: The actual guidelines of cardiovascular prevention lay special emphasis on the lipid-lowering therapy of patients suffering from acute coronary syndrome (ACS). Aim: To evaluate the occurrence of high-intensity statin therapy, recommended by guidelines, at discharge in a Hungarian county hospital with hemodynamic laboratory in patients who underwent percutaneous intervention, furthermore the LDL-cholesterol (LDL-C) levels and goal attainment rate in the first year. Method: Retrospective data collection from the hospital database regarding the therapy at discharge and the lipid levels in the year following the intervention due to ACS in 2015. Results: Due to ACS event, 454 patients had coronary intervention in 2015, at discharge more than 90{\%} of them received high-intensity statin (more than 80{\%} rosuvastatin, 40 mg) or corresponding combination therapy. In 154 cases we found half-year lipid results; the median of LDL-C was 1.9 mmol/L, the 1.8 mmol/L target value attainment rate was 48.7{\%}. Results after one year were found in 292 cases (73{\%} without the deceased and foreign patients); the LDL-C median proved to be 2.0 mmol/L, the target level attainment rate was 37.3{\%}. There was no significant difference between the results of patients from the three different ACS forms and between those of men and women. Conclusions: The lipid lowering therapy of the revascularized patients who come back for medical visits is acceptable, but greater emphasis has to be laid on increasing the rate of controlled patients compared to the present two-thirds.",
keywords = "Acute coronary syndrome, Cardiovascular prevention, Guidelines, Risk factors, Statins",
author = "M{\'a}rk L{\'a}szl{\'o} and Nagy M{\'a}ria and Dani Győző and Baranyai Csaba and Borb{\'e}ly Marianna and Katona Andr{\'a}s and Z. Jambrik",
year = "2018",
month = "3",
day = "1",
doi = "10.1556/650.2018.31022",
language = "Hungarian",
volume = "159",
pages = "478--484",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "12",

}

TY - JOUR

T1 - Akut coronariaszindróma miatt 2015-ben kezelt betegeink lipidcsökkentő terápiája

AU - László, Márk

AU - Mária, Nagy

AU - Győző, Dani

AU - Csaba, Baranyai

AU - Marianna, Borbély

AU - András, Katona

AU - Jambrik, Z.

PY - 2018/3/1

Y1 - 2018/3/1

N2 - Introduction: The actual guidelines of cardiovascular prevention lay special emphasis on the lipid-lowering therapy of patients suffering from acute coronary syndrome (ACS). Aim: To evaluate the occurrence of high-intensity statin therapy, recommended by guidelines, at discharge in a Hungarian county hospital with hemodynamic laboratory in patients who underwent percutaneous intervention, furthermore the LDL-cholesterol (LDL-C) levels and goal attainment rate in the first year. Method: Retrospective data collection from the hospital database regarding the therapy at discharge and the lipid levels in the year following the intervention due to ACS in 2015. Results: Due to ACS event, 454 patients had coronary intervention in 2015, at discharge more than 90% of them received high-intensity statin (more than 80% rosuvastatin, 40 mg) or corresponding combination therapy. In 154 cases we found half-year lipid results; the median of LDL-C was 1.9 mmol/L, the 1.8 mmol/L target value attainment rate was 48.7%. Results after one year were found in 292 cases (73% without the deceased and foreign patients); the LDL-C median proved to be 2.0 mmol/L, the target level attainment rate was 37.3%. There was no significant difference between the results of patients from the three different ACS forms and between those of men and women. Conclusions: The lipid lowering therapy of the revascularized patients who come back for medical visits is acceptable, but greater emphasis has to be laid on increasing the rate of controlled patients compared to the present two-thirds.

AB - Introduction: The actual guidelines of cardiovascular prevention lay special emphasis on the lipid-lowering therapy of patients suffering from acute coronary syndrome (ACS). Aim: To evaluate the occurrence of high-intensity statin therapy, recommended by guidelines, at discharge in a Hungarian county hospital with hemodynamic laboratory in patients who underwent percutaneous intervention, furthermore the LDL-cholesterol (LDL-C) levels and goal attainment rate in the first year. Method: Retrospective data collection from the hospital database regarding the therapy at discharge and the lipid levels in the year following the intervention due to ACS in 2015. Results: Due to ACS event, 454 patients had coronary intervention in 2015, at discharge more than 90% of them received high-intensity statin (more than 80% rosuvastatin, 40 mg) or corresponding combination therapy. In 154 cases we found half-year lipid results; the median of LDL-C was 1.9 mmol/L, the 1.8 mmol/L target value attainment rate was 48.7%. Results after one year were found in 292 cases (73% without the deceased and foreign patients); the LDL-C median proved to be 2.0 mmol/L, the target level attainment rate was 37.3%. There was no significant difference between the results of patients from the three different ACS forms and between those of men and women. Conclusions: The lipid lowering therapy of the revascularized patients who come back for medical visits is acceptable, but greater emphasis has to be laid on increasing the rate of controlled patients compared to the present two-thirds.

KW - Acute coronary syndrome

KW - Cardiovascular prevention

KW - Guidelines

KW - Risk factors

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=85044161456&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044161456&partnerID=8YFLogxK

U2 - 10.1556/650.2018.31022

DO - 10.1556/650.2018.31022

M3 - Article

C2 - 29552926

AN - SCOPUS:85044161456

VL - 159

SP - 478

EP - 484

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 12

ER -